Business ❯ Corporate Governance ❯ Executive Accountability

Investor Relations

Shareholder Rights Stock Performance Securities Regulations Market Performance Market Reactions Financial Disclosure Financial Reporting Trip.com Executive Officers Financial Performance Economic Loss Recovery

3 ARTICLES

yesterday

Multiple Law Firms Seek Lead Plaintiffs in Primoris Securities Suit Over Renewables Cost Overruns

The fight for control of investor claims could determine whether alleged estimating and oversight failures that plaintiffs say wiped out billions in market value produce recoveries for shareholders.

4 ARTICLES

yesterday

Erasca Faces Securities Suit Over ERAS-0015 After Patent Claim and Trial Death Disclosures

5 ARTICLES

4mo ago

NuScale Investors Face April 20 Deadline in ENTRA1 Securities Class Action

8 ARTICLES

4mo ago

Trip.com Investors Urged to Seek Lead Role in Securities Suit Before May 11 Deadline

11 ARTICLES

4mo ago

Soleno Therapeutics Sued in Federal Securities Class Action Over DCCR Safety Disclosures

5 ARTICLES

4mo ago

NuScale Sued in Securities Class Action Over ENTRA1 Claims and $495 Million Charge

8 ARTICLES

6mo ago

Fermi Hit With SDNY Securities Class Action Over Project Matador Disclosures

6 ARTICLES

7mo ago

Inspire Medical Investors Face Monday Deadline in Class Action Over Inspire V Rollout

5 ARTICLES

7mo ago

Lead-Plaintiff Deadline Looms in Synopsys Securities Case

5 ARTICLES

7mo ago

Synopsys Investors Face Dec. 30 Deadline in Securities Class Action

8 ARTICLES

8mo ago

Integer Holdings Faces Securities Class Action Over Electrophysiology Outlook

4 ARTICLES

8mo ago

Inspire Medical Investors Face Jan. 5 Lead-Plaintiff Deadline in Suit Over Inspire V Rollout

6 ARTICLES

8mo ago

Inspire Medical Securities Case Enters Lead-Plaintiff Phase Ahead of Jan. 5 Deadline

10 ARTICLES

8mo ago

MoonLake Investors Courted by Law Firms as Lead‑Plaintiff Deadline Nears in SDNY Securities Case

8 ARTICLES

8mo ago

Synopsys Investors Face Dec. 30 Deadline to Seek Lead Role in Securities Class Action

4 ARTICLES

8mo ago

aTyr Securities Suits Intensify as New Filing Expands Class Period Ahead of Dec. 8 Deadline

5 ARTICLES

9mo ago

Investor Relations

Multiple Law Firms Seek Lead Plaintiffs in Primoris Securities Suit Over Renewables Cost Overruns

Multiple Firms Vie to Lead Erasca Securities Suits After April Disclosures

Securities Class Action Filed Against Rackspace Over AI Pivot Claims

Securities Suits Target BitGo After IPO as Firms Race to Lead Litigation

Erasca Faces Securities Suit Over ERAS-0015 After Patent Claim and Trial Death Disclosures

NuScale Investors Face April 20 Deadline in ENTRA1 Securities Class Action

Trip.com Investors Urged to Seek Lead Role in Securities Suit Before May 11 Deadline

Soleno Therapeutics Sued in Federal Securities Class Action Over DCCR Safety Disclosures

NuScale Sued in Securities Class Action Over ENTRA1 Claims and $495 Million Charge

Fermi Hit With SDNY Securities Class Action Over Project Matador Disclosures

Never miss stories about

Investor Relations

Inspire Medical Investors Face Monday Deadline in Class Action Over Inspire V Rollout

Lead-Plaintiff Deadline Looms in Synopsys Securities Case

Synopsys Investors Face Dec. 30 Deadline in Securities Class Action

Integer Holdings Faces Securities Class Action Over Electrophysiology Outlook

Inspire Medical Investors Face Jan. 5 Lead-Plaintiff Deadline in Suit Over Inspire V Rollout

Inspire Medical Securities Case Enters Lead-Plaintiff Phase Ahead of Jan. 5 Deadline

MoonLake Investors Courted by Law Firms as Lead‑Plaintiff Deadline Nears in SDNY Securities Case

Synopsys Investors Face Dec. 30 Deadline to Seek Lead Role in Securities Class Action

aTyr Securities Suits Intensify as New Filing Expands Class Period Ahead of Dec. 8 Deadline

Synopsys Investors Face Dec. 30 Deadline in Securities Class Action Over Design IP Disclosures

Never miss stories about

Investor Relations